The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...
Merck already sells an older pneumococcalvaccine called Pneumovax 23, which protects against 23 strains but is a polysaccharide based shot, so doesn't stimulate as strong an immune response as ...
Pfizer and Merck have each won FDA approvals in the past year for new pneumococcalvaccines, but GSK aims to top both of them with its $2.1 billion acquisition of Affinivax. That biotech’s Phase ...
Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.
Results that may be inaccessible to you are currently showing.